首页> The Journal of clinical investigation> Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression.

Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression.

导出 OA

翻译打印收藏纠错

第一作者： Bing,Song

第一单位： Division of Hematology/Oncology, Department of Medicine, and.

作者： Bing,Song ^[1] ; Su-Hong,Park ^[1] ; Jonathan C,Zhao ^[1] ; Ka-Wing,Fong ^[1] ; Shangze,Li ^[1] ; Yongik,Lee ^[1] ; Yeqing A,Yang ^[1] ; Subhasree,Sridhar ^[1] ; Xiaodong,Lu ^[1] ; Sarki A,Abdulkadir ^[2] ; Robert L,Vessella ^[3] ; Colm,Morrissey ^[3] ; Timothy M,Kuzel ^[1] ; William,Catalona ^[2] ; Ximing,Yang ^[2] ; Jindan,Yu ^[4]

作者单位： Division of Hematology/Oncology, Department of Medicine, and. ^[1] Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. ^[2] Department of Urology, University of Washington, Seattle, Washington, USA. ^[3] Division of Hematology/Oncology, Department of Medicine, and.;Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.;Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. ^[4]

关键词 Genetics Oncology Prostate cancer